Evestra Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.5M
- Investors
-
7
Evestra General Information
Description
Operator of a biopharmaceutical research and development company intended to develop oncology therapeutics. The company's biopharmaceutical research and development services focus on female reproductive health, including fertility control, hormone replacement therapy, and endometriosis, as well as hormonally regulated cancers, such as breast cancer, enabling patients, their families, and care providers to respond to critical ailments in time.
Contact Information
Website
www.evestra.comCorporate Office
- 6410 Tri County Parkway
- Schertz, TX 78154
- United States
Corporate Office
- 6410 Tri County Parkway
- Schertz, TX 78154
- United States
Evestra Timeline
Evestra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 06-Sep-2022 | $1.5M | 000.00 | Completed | Generating Revenue | |
| 11. Grant | 31-Dec-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
| 10. Debt - PPP | 30-Apr-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
| 9. Grant | 02-Apr-2019 | 00000 | 000.00 | Completed | Generating Revenue | |
| 8. Grant | 22-Feb-2018 | 00000 | 000.00 | Completed | Generating Revenue | |
| 7. Later Stage VC | 16-Jan-2018 | 000 | 000.00 | Completed | Generating Revenue | |
| 6. Grant | 17-May-2017 | 00000 | 00.00 | Completed | Startup | |
| 5. Grant | 24-Jan-2017 | 00.00 | 00.00 | Completed | Startup | |
| 4. Grant | 18-Jan-2016 | $8.7M | Completed | Startup | ||
| 3. Later Stage VC | 26-Jan-2013 | $50K | $8.7M | Completed | Startup |
Evestra Comparisons
Industry
Financing
Details
000000
000000
Evestra Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ascend Therapeutics (Besins Healthcare) | Corporation | Herndon, VA | ||||
| Evofem Biosciences | Formerly VC-backed | San Diego, CA | 00 | 00000 | 000000&0 | 00000 |
| Proteomics International Laboratories | Corporation | Nedlands, Australia | 000.00 | 000000000 | 000.00 | |
| Prasco Laboratories | Corporation | Mason, OH | 000 |
Evestra Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Evestra Patents
Evestra Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240124515-A1 | Orally active leukemia inhibitory factor (lif) antagonists for the treatment of cancer | Pending | 29-Jan-2021 | 0000000000 | |
| US-20200383906-A1 | Hormonal contraception using a vaginal ring which releases estriol and trimegestone | Inactive | 06-Jun-2019 | 0000000000 | |
| US-20200237656-A1 | Drug device combination for the effective treatment of incontinence in women | Inactive | 27-Nov-2018 | 0000000000 | |
| US-20200087340-A1 | Lif/lifr antagonist in oncology and nonmalignant diseases | Inactive | 13-Sep-2018 | 000000000 | |
| CA-3098555-A1 | Targeted delivery of progestins and estrogens via vaginal ring devices for fertility control and hrt products | Inactive | 27-Apr-2018 | A61F6/142 |
Evestra Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Laura Hidalgo | Manager of Administration and Finance | |
| Ze'ev Shaked Ph.D | President & Chief Executive Officer |
Evestra Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| John Kerr JD | Self | Chairman | 000 0000 |
| Lutz Lingnau | Self | Board Observer | 000 0000 |
| Richard Schlosberg III | Self | Board Member | 000 0000 |
Evestra Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Evestra Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | |
| United States Department of Defense | Government | 000 0000 | 000000 0 | |
| Chemical Works of Gedeon Richter | Corporation | 000 0000 | 000000 0 | |
| Schertz EDC | Government | 000 0000 | 000000 0 | |
| European Commission | Government | 000 0000 | 000000 0 |
Evestra FAQs
-
When was Evestra founded?
Evestra was founded in 2008.
-
Who is the founder of Evestra?
P. Narashima Rao and Klaus Nickisch Ph.D are the founders of Evestra.
-
Who is the CEO of Evestra?
Ze'ev Shaked Ph.D is the CEO of Evestra.
-
Where is Evestra headquartered?
Evestra is headquartered in Schertz, TX.
-
What is the size of Evestra?
Evestra has 16 total employees.
-
What industry is Evestra in?
Evestra’s primary industry is Biotechnology.
-
Is Evestra a private or public company?
Evestra is a Private company.
-
What is Evestra’s current revenue?
The current revenue for Evestra is 00000.
-
How much funding has Evestra raised over time?
Evestra has raised $13.7M.
-
Who are Evestra’s investors?
National Institutes of Health, United States Department of Defense, Chemical Works of Gedeon Richter, Schertz EDC, and European Commission are 5 of 7 investors who have invested in Evestra.
-
Who are Evestra’s competitors?
Ascend Therapeutics (Besins Healthcare), Evofem Biosciences, Proteomics International Laboratories, and Prasco Laboratories are competitors of Evestra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
